$251.03
2.350.94%
At Close: -
$251.03
00.00%
After Hours: 4:38 PM EDT
15 minutes delayed
Alnylam Pharmaceuticals
ALNYNASDAQ
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $1.73B | $1.93B | $1.85B | Get Alert |
| 02/15/2024 | ALNY | Alnylam Pharmaceuticals | FY | 2024 | — | — | — | $1.73B | $1.93B | $1.78B | Get Alert |
| 11/02/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.77B | $1.91B | $1.44B | Get Alert |
| 08/03/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.44B | Get Alert |
| 05/04/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.39B | Get Alert |
| 02/23/2023 | ALNY | Alnylam Pharmaceuticals | FY | 2023 | — | — | — | $1.30B | $1.46B | $1.48B | Get Alert |
| 10/27/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $970.00M | $1.08B | $1.07B | Get Alert |
| 07/28/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $970.00M | $1.08B | $1.09B | Get Alert |
| 04/28/2022 | ALNY | Alnylam Pharmaceuticals | FY | 2022 | — | — | — | $870.00M | $930.00M | $1.17B | Get Alert |
| 10/28/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $790.00M | $865.00M | $853.11M | Get Alert |
| 08/03/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $790.00M | $865.00M | $837.45M | Get Alert |
| 04/29/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $760.00M | $860.00M | $824.74M | Get Alert |
| 02/11/2021 | ALNY | Alnylam Pharmaceuticals | FY | 2021 | — | — | — | $760.00M | $860.00M | $796.86M | Get Alert |
FAQ
What is the most recent guidance for Alnylam Pharmaceuticals (ALNY)?
There have been no specific sales or earnings guidance reported for Alnylam Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.